PML/RARα plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells

Thrombosis and Haemostasis

Volumn 90, Issue 5, 2003, Pages 930-939

  Tenno, Taavo ^a,b   Öberg, Fredrik ^a   Mackman, Nigel ^c   Nilsson, Kenneth ^a   Siegbahn, Agneta ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Acute promyelocytic leukemia; AP 1; PML RAR ; Retinoic acid; Tissue factor

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; LUCIFERASE; MESSENGER RNA; ONCOPROTEIN; PROTEIN C FOS; PROTEIN C JUN; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA AGONIST; RETINOIC ACID RECEPTOR ALPHA ANTAGONIST; RETINOID; RO 41 5253; THROMBOPLASTIN; UNCLASSIFIED DRUG; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR AP 1; TUMOR PROTEIN;

ARTICLE; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; ONCOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 0242606421     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-02-0087     Document Type: Article

References (47)

1. Edgington TS, Mackman N, Brand K, et al. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
2. Falanga A, Iacoviello L, Evangelista V, et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 1995; 86: 1072-81.
3. Tenno T, Öberg F, Nilsson K, et al. Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production. Eur J Haematol 1999; 63: 112-9.
4. Conese M, Montemurro P, Fumarulo R, et al. Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes. Thromb Haemost 1991; 66: 662-5.
5. Ott I, Fischer EG, Miyagi Y, et al. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140: 1241-53.
6. Siegbahn A, Johnell M, Rorsman C, et al. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood 2000; 96: 3452-8.
7. Bromberg ME, Konigsberg WH, Madison JF, et al. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 1995; 92: 8205-9.
8. Carmeliet P, Mackman N, Moons L, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-5.
9. Minucci S, Pelicci PG. Retinoid receptors in health and disease: Co-regulators and the chromatin connection. Semin Cell Dev Biol 1999; 10: 215-25.
10. Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-215.
11. Lin RJ, Egan DA, Evans RM. Molecular genetics of acute promyelocytic leukemia. Trends Genet 1999; 15: 179-84.
12. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78: 747-54.
13. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J Exp Med 1991; 174: 1517-26.
14. Oeth PA, Parry GC, Kunsch C, et al. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol Cell Biol 1994; 14: 3772-81.
15. Oeth PA, Yao J, Fan ST, et al. Retinoic acid selectively inhibits lipopolysaccharide induction of tissue factor gene expression in human monocytes. Blood 1998; 91: 2857-65.
16. Koyama T, Hirosawa S, Kawamata N, et al. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: Distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 1994; 84: 3001-9.
17. Tenno T, Botling J, Öberg F, et al. The role of RAR and RXR activation in retinoid-induced tissue factor suppression. Leukemia 2000; 14: 1105-11.
18. Lanotte M, Martin-Thouvenin V, Najman S, et al. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-6.
19. Sundström C, Nilsson K. Establishment and characterization of a human histocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565-77.
20. Grignani F, Ferrucci PF, Testa U, et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423-31.
21. Boehm MF, McClurg MR, Pathirana C, et al. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem 1994; 37: 408-14.
22. Bollag W, Isnardi L, Jablonska S, et al. Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer 1997; 70: 470-2.
23. Apfel C, Bauer F, Crettaz M, et al. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A 1992; 89: 7129-33.
24. Mackman N, Fowler BJ, Edgington TS, et al. Functional analysis of human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A 1990; 87: 2254-8.
25. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 1995; 15: 612-21.
26. Dimberg A, Nilsson K, Öberg F. Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood 2000; 96: 2870-8.
27. Andrews NC, Faller DV. A rapid micro-preparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991: 19: 2499.
28. Oeth PA, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-κB/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365-74.
29. Raelson JV, Nervi C, Rosenauer A, et al. The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996; 88: 2826-32.
30. Nervi C, Ferrara FF, Fanelli M, et al. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein. Blood 1998; 92: 2244-51.
31. Warrell RP, Jr., De The H, Wang ZY, et al. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177-89.
32. Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991; 103: 171-7.
33. Grignani F, Valtieri M, Gabbianelli M, et al. PML/RARα fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood 2000; 96: 1531-7.
34. Weis K, Rambaud S, Lavau C, et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 1994; 76: 345-56.
35. Alcalay M, Tomassoni L, Colombo E, et al. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 1998; 18: 1084-93.
36. LaMorte VJ, Dyck JA, Ochs RL, et al. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A 1998; 95: 4991-6.
37. Liu SL, Rand A, Kelm RJ, Jr., Getz MJ. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts. Oncogene 2000; 19: 3352-62.
38. Parry GC, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J Immunol 1997; 159: 5450-6.
39. Ollivier V, Parry GCN, Cobb RR, et al. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996; 271: 20828-35.
40. Lee DU, Agarwal S, Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 2002; 16: 649-60.
41. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99: 3740-5.
42. Yoshida H, Kitamura K, Tanaka K, et al. Accelerated degradation of PML-retinoic acid receptor α (PML-RARα) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway. Cancer Res 1996; 56: 2945-8.
43. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-54.
44. Groupp ER, Donovan Peluso M. Lipopolysaccharide induction of THP-1 cells activates binding of c-Jun, Ets, and Egr-1 to the tissue factor promoter. J Biol Chem 1996; 271: 12423-30.
45. Vallian S, Gaken JA, Gingold EB, et al. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene 1998; 16: 2843-53.
46. Schüle R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci U S A 1991; 88: 6092-6.
47. Zhou XF, Shen XQ, Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 1999; 13: 276-85.